Table 1.

Baseline characteristics of nonalcoholic fatty liver disease (NAFLD) patients and controls.

Group	No-NAFLD (n = 276)	NAFLD (n = 101)	P Value
Demographics
Age (mean, range)	64.4 ± 19.6	64.9 ± 15.9	P = .81
Sex n (%)			P = .034
Male	124 (45%)	33 (32.7%)
Female	152 (55%)	68 (67.3%)
Country of birth (Israel) n (%)	165 (59.8%)	58 (57.4%)	P = .72
BMI (mean ± SD)	26.81 ± 5.6	33.16 ± 6.78	P < .001
BMI ≥ 30 n (%)	55 (28.9%)	62 (63.3%)	P < .001
Hospitalization facts
Hospital stay (d)	6 [3–10]	6 [3–12]	P = .61
Department			P = .25
Internal	225 (88%)	82 (81%)
Surgery	22 (9%)	13 (13%)
Genecology	9 (3%)	6 (6%)
Background history
Diabetes n (%)	85 (30.8%)	41 (40.5%)	P = .03
Hypertension n (%)	142 (51.4%)	62 (61.4%)	P = .08
Dyslipidemia n (%)	118 (43%)	48 (47.5%)	P = .13
Ischemic heart disease n (%)	51 (18.6%)	24 (23.7%)	P = .09
Cerebrovascular accident n (%)	20 (7%)	11 (11%)	P = .19
Antiplatelet medications n (%)	87 (31.5%)	37 (36.6%)	P = .26
Recent surgery n (%)	16 (5.8%)	8 (7.9%)	P = .48
Hormonal therapy n (%)	1 (0.3%)	0 (0.0%)	P = .92
Recent trauma n (%)	11 (4%)	5 (5%)	P = .77
Active malignancy n (%)	32 (11.6%)	20 (19.8%)	P = .045
Smoking n (%)	52 (18.9%)	21 (20.8%)	P = .66
Primary outcome
Pulmonary embolism n (%)	147 (53.3%)	80 (79.2%)	P < .001